Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Covington Successfully Defends Lilly in $1+ Billion Trade Secret Arbitration

August 23, 2019

WASHINGTONCovington has secured a complete victory for our client Eli Lilly & Company against French biotech company Adocia S.A., defeating Adocia’s claims of $1.39 billion for alleged misappropriation of trade secrets in an arbitration before a three-member panel at the American Arbitration Association (AAA).  After extensive written submissions and a lengthy hearing, the Tribunal unanimously concluded that Lilly engaged in no wrongdoing and is not liable for damages.

The dispute concerned allegations that Lilly had misused Adocia trade secrets and confidential information in developing Lilly’s own rapid-acting insulin. In dismissing Adocia’s claims, the Tribunal recognized Lilly’s extensive record of independent development.

“We are very pleased that the Tribunal acknowledged the innovative and independent work of Lilly scientists,” said Marney L. Cheek, lead counsel for Lilly. “We are delighted with the outcome.”

The Covington lawyers working with the Lilly in-house legal team also included partners Clara J. Shin and Jeffrey M. Davidson in San Francisco and Megan P. Keane and Miguel López Forastier in Washington, D.C.; associates Jared Frisch and Clovis Trevino in Washington, D.C.; Isaac ChaputUdit Sood, Dylan Silva, Kanu Song, and Breanna Jones in San Francisco, and Andrew Regan in Palo Alto.

 

Share this article: